DIN 02469723 — BAVENCIO 20 MG
BAVENCIO is a solution of Avelumab marketed by EMD SERONO, A DIVISION OF EMD INC., CANADA. The full Avelumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02469723
- Brand name
- BAVENCIO
- Active ingredient
- Avelumab
- Strength
- 20 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- EMD SERONO, A DIVISION OF EMD INC., CANADA
- Health Canada status
- MARKETED
- Drug class
- PD-L1 immune checkpoint inhibitor (antineoplastic monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.